Skip to main content

Table 2 Spleen weight and frequencies of spleen cell subpopulations and peripheral leukocyte subsets in untreated, normal rat IgG-treated, and 5C6-treated KO1 micea

From: Anti-CD11b antibody treatment suppresses the osteoclast generation, inflammatory cell infiltration, and autoantibody production in arthritis-prone FcγRIIB-deficient mice

 

Treatment

None

Rat IgG

5C6

Spleen weight (g)

0.20 ± 0.05

0.19 ± 0.04

0.19 ± 0.02

Spleen cell populations (%)

 B220+B cells/total cells

48.0 ± 2.7

47.7 ± 3.3

56.4 ± 1.9b

 CD69+B220+ B cells/total B cells

5.3 ± 1.9

4.5 ± 1.0

2.7 ± 0.2b

 PNA+B220+ B cells/total B cells

3.8 ± 1.2

3.9 ± 0.5

1.2 ± 0.1c

 CD138+plasma cells/total cells

2.1 ± 0.5

1.7 ± 0.2

1.1 ± 0.2d

 CD4+T cells/total cells

17.5 ± 0.4

16.2 ± 0.8

17.3 ± 0.7

 CD69+CD4+ T cells/total T cells

35.9 ± 4.2

29.9 ± 2.5

34.64 ± 1.53

 CD11b+ cells/total cells

12.0 ± 2.5

ND

9.1 ± 1.5

 CD11c+ cells/total cells

6.9 ± 1.3

ND

5.8 ± 0.6

Peripheral blood (%)

 Neutrophils/total cells

16.8 ± 1.7

ND

9.5 ± 2.4

 Monocytes/total cells

54.0 ± 2.3

50.5 ± 11.9

41.3 ± 1.8b

 Gr-1+ monocytes/total cells

6.2 ± 1.4

ND

4.4 ± 0.6

 Gr-1- monocytes/total cells

47.8 ± 1.7

ND

37.0 ± 1.8e

  1. ND not defined, 5C6 anti-mouse CD11b monoclonal antibody, KO1 FcγRIIB-deficient mouse strain
  2. aValues are the mean ± SEM of at least 6 female mice aged 10 months
  3. bDifferences were statistically significant versus untreated KO1 and versus normal rat IgG-treated KO1 (analysis of variance (ANOVA) P < 0.05)
  4. cDifferences were statistically significant versus untreated KO1 and versus normal rat IgG-treated KO1 (ANOVA P < 0.01)
  5. dDifferences were statistically significant versus untreated KO1 (ANOVA P < 0.01) and versus normal rat IgG-treated KO1 (ANOVA P < 0.05)
  6. eDifference was statistically significant versus untreated KO1 (Student’s t test P < 0.05)